Alejandra Carvajal
Net worth: - $ as of 31/12/2025
Net worth: - $ as of 31/12/2025
Alejandra Veronica Carvajal is currently Director at Science Club For Girls, Member at Massachusetts Bar Association, and Chief Legal Officer at CytomX Therapeutics, Inc. Starting in 2026, the role at CytomX Therapeutics, Inc. is ongoing.
Former roles include Partner-R&D, Business Development & Manufacturing at Millennium Pharmaceuticals, Inc., Secretary, Chief Legal Officer & General Counsel at Momenta Pharmaceuticals, Inc. from 2018 to 2021, Attorney at Day, Berry & Howard LLP, Attorney at Hill & Barlow, Inc., Vice President & General Counsel at Cerulean Pharma, Inc. from 2014 to 2017, and Chief Legal Officer & Senior Vice President at Mersana Therapeutics, Inc. from 2021 to 2026.
Education includes undergraduate studies at Harvard University and graduate studies at Georgetown University Law Center.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/01/2026 | 0 ( -.--% ) | - $ | 31/12/2025 |
| Companies | Position | Start |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | General Counsel | 03/08/2026 |
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as lawyers association | Corporate Officer/Principal | - |
Science Club For Girls
Science Club For Girls Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides science, technology, engineering and mathematics support services | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| MERSANA THERAPEUTICS | General Counsel | 06/01/2026 |
| MOMENTA PHARMACEUTICALS, INC. | General Counsel | 01/03/2021 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | General Counsel | 01/06/2017 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Private Equity Analyst | - |
Hill & Barlow, Inc. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Day, Berry & Howard LLP
Day, Berry & Howard LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Hill & Barlow, Inc. | Commercial Services |
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as lawyers association | Commercial Services |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
Science Club For Girls
Science Club For Girls Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides science, technology, engineering and mathematics support services | Commercial Services |
Georgetown University Law Center
Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions